In the female: Puregon is indicated for the treatment of female infertility in the following clinical situations: Anovulation (including polycystic ovarian syndrome, (PCOS) in women who have been unresponsive to treatment with clomifene citrate.
Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [e.g. in vitro fertilization/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)].
In the male: Deficient spermatogenesis due to hypogonadotrophic hypogonadism.